20 articles
A comprehensive review reveals how one gut bacterium influences metabolism, immunity, cancer response, and longevity across multiple disease states.
A gut bacterium celebrated for metabolic benefits may have a complex, sometimes harmful role in stroke, Parkinson's, Alzheimer's, and MS.
A gut microbiome study links lactic acid and Akkermansia muciniphila to reduced anxiety by boosting serotonin production from tryptophan.
Gut microbes deploy reversible DNA methylation changes to adapt to antibiotics and fecal transplants — even beneficial Akkermansia uses this strategy.
Researchers identify Limousia bacteria with unique molecular machinery for degrading intestinal mucus, revealing new microbe-host interactions.
Study shows probiotic bacteria shields heart muscle from toxic effects of cancer chemotherapy through metabolite pathway.
New research reveals how specific gut bacteria produce enzymes that can degrade the intestinal mucus layer that protects us from pathogens.
Shotgun sequencing reveals specific gut microbes linked to amyloid burden and tau pathology in mild cognitive impairment patients.
Researchers discover N-acetylmuramic acid from gut microbes inhibits colorectal cancer by blocking AKT1 signaling, offering new prevention insights.
Scientists identify how mysterious gut bacteria process nutrients, potentially opening new avenues for microbiome-based health interventions.
New research reveals how Bilophila wadsworthia uses bacterial microcompartments to colonize the gut during high-fat diets.
New research reveals how Enterococcus faecalis bacteria produce lactic acid to disable immune defenses, enabling persistent wound infections.
Study reveals how specific gut microbes protect against cardiovascular inflammation, offering new therapeutic targets for vasculitis.
New research reveals archaea in saliva and plaque, with reduced methanogen activity linked to dental caries development.
A comprehensive review reveals how probiotics, bacteriophages, and predatory bacteria can restore oral microbial balance and prevent systemic disease.
A microbiota-derived short-chain fatty acid stops Candida colonization by acidifying fungal cells — a finding with major implications for immunocompromised patients.
Large study identifies 35 gut bacteria that differ in Alzheimer's patients, with specific markers varying by ethnicity and geography.
New research reveals how microbiota-produced SCFAs directly block Candida albicans growth, pointing to prebiotic therapies for immunocompromised patients.
New research reveals how different Neisseria bacteria colonize specific sites in the mouth, with unique genetic adaptations for each habitat.
Review reveals how periodontal pathogens like P. gingivalis cross into the brain, triggering amyloid buildup and cognitive decline.
